Biotech Stocks
Biotechnology companies developing drugs, therapies, and medical innovations.
50 stocks
| # | Symbol | Price | Change | Market Cap | P/E | Rating |
|---|---|---|---|---|---|---|
| 1 | VRTX Vertex Pharmaceuticals Incorporated | $460.82 | -3.57% | $114.46B | 31.0 | |
| 2 | REGN Regeneron Pharmaceuticals, Inc. | $764.93 | -2.87% | $77.16B | 16.9 | |
| 3 | VRNA Verona Pharma plc | $106.91 | +0.11% | $72.68B | — | |
| 4 | ARGX argenx SE | $728.11 | -2.86% | $47.46B | 42.3 | |
| 5 | ALNY Alnylam Pharmaceuticals, Inc. | $320.51 | -2.07% | $44.15B | 140.3 | |
| 6 | SGEN Seagen Inc. | $228.74 | -0.07% | $43.15B | — | |
| 7 | BNTX BioNTech SE | $101.95 | -1.78% | $23.08B | — | — |
| 8 | BGNE BeiGene, Ltd. | $184.71 | +0.49% | $20.21B | 515.3 | — |
| 9 | GMAB Genmab A/S | $27.48 | -2.48% | $19.89B | 14.6 | — |
| 10 | INCY Incyte Corporation | $97.33 | -1.55% | $18.86B | 15.8 | — |
| 11 | RPRX Royalty Pharma plc | $45.68 | -3.69% | $16.85B | 16.4 | — |
| 12 | RVMD Revolution Medicines, Inc. | $99.64 | -1.53% | $15.18B | — | — |
| 13 | ROIV Roivant Sciences Ltd. | $29.72 | +0.68% | $14.83B | — | — |
| 14 | ASND Ascendis Pharma A/S | $237.35 | -1.67% | $14.33B | — | — |
| 15 | BBIO BridgeBio Pharma, Inc. | $66.17 | -0.56% | $14.11B | — | — |
| 16 | SMMT Summit Therapeutics Inc. | $14.94 | -2.86% | $13.39B | — | — |
| 17 | MDGL Madrigal Pharmaceuticals, Inc. | $439.34 | +1.04% | $12.67B | — | — |
| 18 | KRTX Karuna Therapeutics, Inc. | $329.83 | +0.03% | $12.60B | — | |
| 19 | IONS Ionis Pharmaceuticals, Inc. | $75.16 | -5.40% | $12.57B | — | — |
| 20 | MRNA Moderna, Inc. | $53.83 | -6.87% | $11.57B | — | |
| 21 | EXEL Exelixis, Inc. | $41.28 | -0.98% | $11.10B | 16.4 | — |
| 22 | BMRN BioMarin Pharmaceutical Inc. | $60.57 | +0.23% | $10.18B | 19.6 | — |
| 23 | JAZZ Jazz Pharmaceuticals plc | $183.63 | -2.68% | $10.02B | — | — |
| 24 | RXDX Prometheus Biosciences, Inc. | $199.92 | +0.09% | $9.56B | — | — |
| 25 | TECH Bio-Techne Corporation | $55.89 | -3.39% | $9.45B | 120.1 | |
| 26 | RNA Avidity Biosciences, Inc. | $15.47 | -6.47% | $9.40B | — | — |
| 27 | CORT Corcept Therapeutics Incorporated | $34.04 | -4.62% | $9.17B | 85.8 | — |
| 28 | ARWR Arrowhead Pharmaceuticals, Inc. | $63.60 | -2.30% | $8.86B | 43.8 | — |
| 29 | IMGN ImmunoGen, Inc. | $31.24 | +0.02% | $8.73B | — | — |
| 30 | BPMC Blueprint Medicines Corporation | $129.46 | +0.14% | $8.36B | — | |
| 31 | CERE Cerevel Therapeutics Holdings, Inc. | $44.96 | +0.74% | $8.19B | — | — |
| 32 | ABVX Abivax S.A. | $112.70 | -3.49% | $7.95B | — | — |
| 33 | RYTM Rhythm Pharmaceuticals, Inc. | $91.46 | +0.51% | $7.84B | — | — |
| 34 | NUVL Nuvalent, Inc. | $100.13 | -2.47% | $7.69B | — | — |
| 35 | AXSM Axsome Therapeutics, Inc. | $161.46 | -1.60% | $7.50B | — | — |
| 36 | CAI Caris Life Sciences, Inc. | $19.22 | -3.22% | $7.49B | — | |
| 37 | MTSR Metsera, Inc. | $70.50 | -0.35% | $7.43B | — | |
| 38 | MRUS Merus N.V. | $90.00 | +0.00% | $7.33B | — | — |
| 39 | HALO Halozyme Therapeutics, Inc. | $67.36 | -3.80% | $7.28B | 12.2 | — |
| 40 | CYTK Cytokinetics, Incorporated | $62.19 | -0.13% | $7.23B | — | — |
| 41 | KRYS Krystal Biotech, Inc. | $260.33 | -1.76% | $7.16B | 35.9 | |
| 42 | ACLX Arcellx, Inc. | $114.36 | +0.05% | $6.58B | — | — |
| 43 | RETA Reata Pharmaceuticals, Inc. | $172.36 | +0.02% | $6.57B | — | — |
| 44 | KYMR Kymera Therapeutics, Inc. | $83.52 | -3.01% | $6.32B | — | — |
| 45 | PTCT PTC Therapeutics, Inc. | $63.33 | -1.49% | $6.05B | 7.9 | — |
| 46 | PCVX Vaxcyte, Inc. Common Stock | $58.25 | -3.13% | $5.84B | — | — |
| 47 | PTGX Protagonist Therapeutics, Inc. | $91.41 | -3.61% | $5.77B | 128.1 | — |
| 48 | COGT Cogent Biosciences, Inc. Common Stock | $37.46 | +1.19% | $5.70B | — | — |
| 49 | PRAX Praxis Precision Medicines, Inc. | $310.58 | -4.47% | $5.65B | — | |
| 50 | CDTX Cidara Therapeutics, Inc. | $221.38 | +0.00% | $5.58B | — | — |
About Biotech Stocks
Biotechnology companies developing drugs, therapies, and medical innovations.
